Table 2. Kaplan-Meier probability of HIV-1 RNA rebound during follow-up on treatment after measurement of cell-associated HIV-1 DNA.
Cell-associated HIV-1 DNAa | ||||
---|---|---|---|---|
≤55 copies/106 cells | >55 copies/106 cells | Log-rank p-value | ||
N | 74 | 71 | ||
Hazard Ratio from Cox model comparing HIV-1 DNA >55 to ≤ 55 copies/106 cells | ||||
Probability of HIV-1 RNA >___ by ____ months (N with event) | ||||
>50 copies/ml | ||||
12 months | 0.1020 (7) | 0.1699 (10) | ||
24 months | 0.3681 (24) | 0.4878 (28) | ||
36 months | 0.4629 (30) | 0.7008 (40) | 0.0006 | 2.07(95% CI: 1.352–3.167) |
>400 copies/ml | ||||
12 months | 0.0137 (1) | 0.0837 (5) | ||
24 months | 0.1383 (9) | 0.2274 (13) | ||
36 months | 0.1696 (11) | 0.3177 (18) | 0.0021 | 2.641 (95%CI: 1.389–5.022) |
>1000 copies/ml | ||||
12 months | 0.0137 (1) | 0.0837 (5) | ||
24 months | 0.0915 (6) | 0.1915 (11) | ||
36 months | 0.1072 (7) | 0.2458 (14) | 0.0187 | 2.526 (95%CI: 1.134–5.626) |
a One child had no follow-up after HIV-1 DNA measurement and was excluded from this analysis.